project id: TCGA-KIRP; case submitter id: TCGA-UZ-A9PQ; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.08; rna integrity number: 9.4; age at index: 59; days to birth: -21550; days to death: 2624; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Dead; age at diagnosis: 21550; ajcc clinical m: M0; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage III; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to last follow up: 2182.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 1280.0; portion submitter id: TCGA-UZ-A9PQ-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 90.0;